WINT - Windtree Therapeutics announces 1-for-50 reverse stock split

• Windtree Therapeutics ( NASDAQ: WINT ) board approved a 1-for-50 reverse stock split of its issued and outstanding common stock, effective Feb.24 after market opens.
• The stock will commence trading under the same symbol.
• The company expects the reverse stock split, approved on Feb.7, will increase the market price per share thereby leading to the company into compliance with listing requirements of the minimum bid price requirement by The Nasdaq Capital Market.
• The split will reduce the number of shares of outstanding common stock from ~44.5M shares to ~0.9M shares.

For further details see: